MedTrace Logo

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

NCT06688825 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-06

No results posted yet for this study

Summary

This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) patient education using a proven weight loss curriculum, and (2) technology tools for making healthy lifestyle choices.

Conditions

  • Kidney Transplant; Complications
  • Obesity

Interventions

BEHAVIORAL

Education regarding Weight loss

Per American Association of Clinical Endocrinology (AACE) guidelines

BEHAVIORAL

Lifestyle tools for weight loss

Calorie App, Continuous GlucosWe Monitor (CGM), Weight Scale, Food Scale

BIOLOGICAL

Blood draw

Per American Association of Clinical Endocrinology (AACE) guidelines

Sponsors & Collaborators

  • American Society of Health-System Pharmacists Research and Education Foundation

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Evan Sisson · Virginia Commonwealth University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06688825 on ClinicalTrials.gov